Hyponatremia in heart failure
- PMID: 18758941
- DOI: 10.1007/s10741-008-9109-7
Hyponatremia in heart failure
Abstract
Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with heart failure. It may occur in patients who have hypovolemic, hypervolemic, or euvolemic state. It is usually not corrected by available therapies. It is a major predictor of prognosis, and correction of hyponatremia can be effectively accomplished by vasopressin antagonists. However, it still remains to be seen whether the normalization of serum sodium with vasopressin antagonists will also lead to an improved long-term prognosis.
Comment in
-
Hyponatremia in heart failure: concluding remarks.Heart Fail Rev. 2009 Jun;14(2):87-8. doi: 10.1007/s10741-008-9106-x. Epub 2008 Aug 29. Heart Fail Rev. 2009. PMID: 18758942 No abstract available.
Similar articles
-
Introduction: Vasopressin therapy.Heart Fail Rev. 2009 Jun;14(2):57-8. doi: 10.1007/s10741-008-9116-8. Epub 2008 Nov 7. Heart Fail Rev. 2009. PMID: 18989773 No abstract available.
-
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015. Clin Ther. 2010. PMID: 20637957 Review.
-
Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.Int Urol Nephrol. 2012 Jun;44(3):865-71. doi: 10.1007/s11255-011-9996-8. Epub 2011 May 24. Int Urol Nephrol. 2012. PMID: 21607553
-
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.Clin Cardiol. 2010 Nov;33(11):666-71. doi: 10.1002/clc.20822. Clin Cardiol. 2010. PMID: 21089110 Free PMC article. Review.
-
Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.Am J Health Syst Pharm. 2011 Feb 15;68(4):328-33. doi: 10.2146/ajhp100217. Am J Health Syst Pharm. 2011. PMID: 21289328 Clinical Trial.
Cited by
-
Ventricular longitudinal function by cardiovascular magnetic resonance predicts cardiovascular morbidity in HFrEF patients.ESC Heart Fail. 2022 Aug;9(4):2313-2324. doi: 10.1002/ehf2.13916. Epub 2022 Apr 11. ESC Heart Fail. 2022. PMID: 35411699 Free PMC article.
-
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).J Endocrinol Invest. 2018 Jan;41(1):3-19. doi: 10.1007/s40618-017-0776-x. Epub 2017 Nov 20. J Endocrinol Invest. 2018. PMID: 29152673 No abstract available.
-
Arginine vasopressin receptor signaling and functional outcomes in heart failure.Cell Signal. 2016 Mar;28(3):224-233. doi: 10.1016/j.cellsig.2015.07.021. Epub 2015 Jul 30. Cell Signal. 2016. PMID: 26232615 Free PMC article. Review.
-
Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report.Medicine (Baltimore). 2019 Jul;98(27):e16229. doi: 10.1097/MD.0000000000016229. Medicine (Baltimore). 2019. PMID: 31277136 Free PMC article.
-
Is hyponatremia associated with mortality in pulmonary arterial hypertension?Pulm Circ. 2018 Apr-Jun;8(2):2045894018776888. doi: 10.1177/2045894018776888. Epub 2018 Apr 26. Pulm Circ. 2018. PMID: 29697294 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical